Moderate-certainty evidence demonstrated that GLP-1 agonists probably decreased the risk of four-point major adverse cardiovascular events (composite outcome including cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or need for hospitalization or coronary revascularization for unstable angina pectoris or heart failure) compared with placebo over a median 200 weeks of follow-up (risk ratio = 0.77
Your body cant manufacture copper, and no peptide can replace an essential nutrient
The ice nucleation active site density increases with decreasing temperature to a maximum of 4.7 10 3 INPs mg 1 alkaline phosphatase at 25.4 C and colder, compared with a maximum of 4.8 10 3 INPs mg 1 RuBisCO at 8.8 C and colder (Fig
Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: A systematic review and meta-analysis of randomized trials and quasi-randomized trials
The phase 2 trial published in the New England Journal of Medicine documented heart rate increases across every dose group
There have been periodic global shortages of the prescription drugs Ozempic (semaglutide) and Mounjaro (tirzepatide), which are approved by the drug regulator the Therapeutic Goods Administration (TGA) to treat type 2 diabetes